位置:首页 > 蛋白库 > APOA1_GORGO
APOA1_GORGO
ID   APOA1_GORGO             Reviewed;         267 AA.
AC   G3QY98;
DT   21-MAR-2012, integrated into UniProtKB/Swiss-Prot.
DT   16-NOV-2011, sequence version 1.
DT   03-AUG-2022, entry version 66.
DE   RecName: Full=Apolipoprotein A-I;
DE            Short=Apo-AI;
DE            Short=ApoA-I;
DE   AltName: Full=Apolipoprotein A1;
DE   Contains:
DE     RecName: Full=Proapolipoprotein A-I;
DE              Short=ProapoA-I;
DE   Contains:
DE     RecName: Full=Truncated apolipoprotein A-I;
DE   Flags: Precursor;
GN   Name=APOA1;
OS   Gorilla gorilla gorilla (Western lowland gorilla).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Gorilla.
OX   NCBI_TaxID=9595;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Scally A.;
RT   "Insights into the evolution of the great apes provided by the gorilla
RT   genome.";
RL   Submitted (MAY-2011) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=21298813; DOI=10.1016/j.cbd.2009.09.001;
RA   Puppione D.L., Della Donna L., Laganowsky A.D., Bassilian S., Souda P.,
RA   Ryder O.A., Whitelegge J.P.;
RT   "Mass spectral analyses of the two major apolipoproteins of great ape high
RT   density lipoproteins.";
RL   Comp. Biochem. Physiol. 4:305-309(2009).
CC   -!- FUNCTION: Participates in the reverse transport of cholesterol from
CC       tissues to the liver for excretion by promoting cholesterol efflux from
CC       tissues and by acting as a cofactor for the lecithin cholesterol
CC       acyltransferase (LCAT). As part of the SPAP complex, activates
CC       spermatozoa motility (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with APOA1BP and CLU.
CC       Component of a sperm activating protein complex (SPAP), consisting of
CC       APOA1, an immunoglobulin heavy chain, an immunoglobulin light chain and
CC       albumin. Interacts with NDRG1. Interacts with SCGB3A2 (By similarity).
CC       Interacts with NAXE and YJEFN3 (By similarity).
CC       {ECO:0000250|UniProtKB:G5BQH5, ECO:0000250|UniProtKB:P02647,
CC       ECO:0000250|UniProtKB:P04639}.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Major protein of plasma HDL, also found in
CC       chylomicrons.
CC   -!- PTM: Glycosylated. {ECO:0000250}.
CC   -!- PTM: Palmitoylated. {ECO:0000250}.
CC   -!- PTM: Phosphorylation sites are present in the extracellular medium.
CC       {ECO:0000250}.
CC   -!- MASS SPECTROMETRY: [Apolipoprotein A-I]: Mass=28078.67;
CC       Mass_error=0.833; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:21298813};
CC   -!- SIMILARITY: Belongs to the apolipoprotein A1/A4/E family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   RefSeq; XP_004052230.1; XM_004052182.2.
DR   AlphaFoldDB; G3QY98; -.
DR   BMRB; G3QY98; -.
DR   SMR; G3QY98; -.
DR   STRING; 9593.ENSGGOP00000007828; -.
DR   PRIDE; G3QY98; -.
DR   Ensembl; ENSGGOT00000008040; ENSGGOP00000007828; ENSGGOG00000008006.
DR   Ensembl; ENSGGOT00000048162; ENSGGOP00000033442; ENSGGOG00000008006.
DR   GeneID; 101137897; -.
DR   KEGG; ggo:101137897; -.
DR   CTD; 335; -.
DR   eggNOG; ENOG502S1XQ; Eukaryota.
DR   GeneTree; ENSGT00950000182929; -.
DR   HOGENOM; CLU_058447_1_0_1; -.
DR   InParanoid; G3QY98; -.
DR   OMA; KEVREMW; -.
DR   OrthoDB; 1553412at2759; -.
DR   Proteomes; UP000001519; Chromosome 11.
DR   Bgee; ENSGGOG00000008006; Expressed in liver and 5 other tissues.
DR   GO; GO:0042627; C:chylomicron; IBA:GO_Central.
DR   GO; GO:0030139; C:endocytic vesicle; IEA:Ensembl.
DR   GO; GO:0034364; C:high-density lipoprotein particle; IBA:GO_Central.
DR   GO; GO:0034366; C:spherical high-density lipoprotein particle; IEA:Ensembl.
DR   GO; GO:0034361; C:very-low-density lipoprotein particle; IEA:Ensembl.
DR   GO; GO:0001540; F:amyloid-beta binding; IEA:Ensembl.
DR   GO; GO:0034191; F:apolipoprotein A-I receptor binding; IEA:Ensembl.
DR   GO; GO:0045499; F:chemorepellent activity; IEA:Ensembl.
DR   GO; GO:0015485; F:cholesterol binding; IBA:GO_Central.
DR   GO; GO:0120020; F:cholesterol transfer activity; IEA:Ensembl.
DR   GO; GO:0019899; F:enzyme binding; IEA:Ensembl.
DR   GO; GO:0031072; F:heat shock protein binding; IEA:Ensembl.
DR   GO; GO:0008035; F:high-density lipoprotein particle binding; IEA:Ensembl.
DR   GO; GO:0070653; F:high-density lipoprotein particle receptor binding; IBA:GO_Central.
DR   GO; GO:0031210; F:phosphatidylcholine binding; IBA:GO_Central.
DR   GO; GO:0060228; F:phosphatidylcholine-sterol O-acyltransferase activator activity; IBA:GO_Central.
DR   GO; GO:0005543; F:phospholipid binding; IBA:GO_Central.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0030325; P:adrenal gland development; IEA:Ensembl.
DR   GO; GO:0043534; P:blood vessel endothelial cell migration; IEA:Ensembl.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; IBA:GO_Central.
DR   GO; GO:0033344; P:cholesterol efflux; IBA:GO_Central.
DR   GO; GO:0042632; P:cholesterol homeostasis; IBA:GO_Central.
DR   GO; GO:0070508; P:cholesterol import; IEA:Ensembl.
DR   GO; GO:0001935; P:endothelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0008211; P:glucocorticoid metabolic process; IEA:Ensembl.
DR   GO; GO:0034380; P:high-density lipoprotein particle assembly; IBA:GO_Central.
DR   GO; GO:0034375; P:high-density lipoprotein particle remodeling; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0019915; P:lipid storage; IEA:Ensembl.
DR   GO; GO:0042158; P:lipoprotein biosynthetic process; IEA:Ensembl.
DR   GO; GO:0042157; P:lipoprotein metabolic process; IBA:GO_Central.
DR   GO; GO:0060354; P:negative regulation of cell adhesion molecule production; IEA:Ensembl.
DR   GO; GO:0002719; P:negative regulation of cytokine production involved in immune response; IEA:Ensembl.
DR   GO; GO:0034115; P:negative regulation of heterotypic cell-cell adhesion; IEA:Ensembl.
DR   GO; GO:0051346; P:negative regulation of hydrolase activity; IEA:Ensembl.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:0032691; P:negative regulation of interleukin-1 beta production; IEA:Ensembl.
DR   GO; GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0010903; P:negative regulation of very-low-density lipoprotein particle remodeling; IEA:Ensembl.
DR   GO; GO:0018206; P:peptidyl-methionine modification; ISS:UniProtKB.
DR   GO; GO:0006656; P:phosphatidylcholine biosynthetic process; IEA:Ensembl.
DR   GO; GO:0046470; P:phosphatidylcholine metabolic process; IBA:GO_Central.
DR   GO; GO:0033700; P:phospholipid efflux; IBA:GO_Central.
DR   GO; GO:0055091; P:phospholipid homeostasis; IEA:Ensembl.
DR   GO; GO:0010875; P:positive regulation of cholesterol efflux; ISS:UniProtKB.
DR   GO; GO:0010873; P:positive regulation of cholesterol esterification; IBA:GO_Central.
DR   GO; GO:0090205; P:positive regulation of cholesterol metabolic process; IEA:Ensembl.
DR   GO; GO:1905920; P:positive regulation of CoA-transferase activity; IEA:Ensembl.
DR   GO; GO:0045723; P:positive regulation of fatty acid biosynthetic process; IBA:GO_Central.
DR   GO; GO:0046889; P:positive regulation of lipid biosynthetic process; IBA:GO_Central.
DR   GO; GO:0051006; P:positive regulation of lipoprotein lipase activity; IBA:GO_Central.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; ISS:UniProtKB.
DR   GO; GO:1902995; P:positive regulation of phospholipid efflux; ISS:UniProtKB.
DR   GO; GO:0035025; P:positive regulation of Rho protein signal transduction; IEA:Ensembl.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; IEA:Ensembl.
DR   GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IEA:Ensembl.
DR   GO; GO:0010898; P:positive regulation of triglyceride catabolic process; IBA:GO_Central.
DR   GO; GO:0018158; P:protein oxidation; ISS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; ISS:UniProtKB.
DR   GO; GO:0032489; P:regulation of Cdc42 protein signal transduction; IEA:Ensembl.
DR   GO; GO:0030300; P:regulation of intestinal cholesterol absorption; IBA:GO_Central.
DR   GO; GO:0001932; P:regulation of protein phosphorylation; IEA:Ensembl.
DR   GO; GO:0043691; P:reverse cholesterol transport; IBA:GO_Central.
DR   GO; GO:0070328; P:triglyceride homeostasis; IBA:GO_Central.
DR   GO; GO:0034372; P:very-low-density lipoprotein particle remodeling; IBA:GO_Central.
DR   GO; GO:0051180; P:vitamin transport; IEA:Ensembl.
DR   InterPro; IPR000074; ApoA_E.
DR   Pfam; PF01442; Apolipoprotein; 1.
PE   1: Evidence at protein level;
KW   Cholesterol metabolism; Glycoprotein; HDL; Lipid metabolism;
KW   Lipid transport; Lipoprotein; Oxidation; Palmitate; Phosphoprotein;
KW   Reference proteome; Repeat; Secreted; Signal; Steroid metabolism;
KW   Sterol metabolism; Transport.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..267
FT                   /note="Proapolipoprotein A-I"
FT                   /id="PRO_0000425321"
FT   CHAIN           25..267
FT                   /note="Apolipoprotein A-I"
FT                   /id="PRO_0000415938"
FT   CHAIN           25..266
FT                   /note="Truncated apolipoprotein A-I"
FT                   /id="PRO_0000416573"
FT   REPEAT          68..89
FT                   /note="1"
FT   REPEAT          90..111
FT                   /note="2"
FT   REPEAT          112..122
FT                   /note="3; half-length"
FT   REPEAT          123..144
FT                   /note="4"
FT   REPEAT          145..166
FT                   /note="5"
FT   REPEAT          167..188
FT                   /note="6"
FT   REPEAT          189..210
FT                   /note="7"
FT   REPEAT          211..232
FT                   /note="8"
FT   REPEAT          233..243
FT                   /note="9; half-length"
FT   REPEAT          244..267
FT                   /note="10"
FT   REGION          68..267
FT                   /note="10 X approximate tandem repeats"
FT   MOD_RES         110
FT                   /note="Methionine sulfoxide"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         136
FT                   /note="Methionine sulfoxide"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   267 AA;  30778 MW;  1A28B8366E620310 CRC64;
     MKAAVLTLAV LFLTGSQARH FWQQDEPPQS PWDRVKDLAT VYVDVLKDSG RDYVSQFEGS
     ALGKQLNLKL LDNWDSVTST FSKLREQLGP VTQEFWDNLE KETEGLRQEM SKDLEEVKAK
     VQPYLDDFQK KWQEEMELYR QKVEPLRAEL QEGARQKLHE LQEKLSPLGE EMRDRARAHV
     DALRTHLAPY SDELRQRLAA RLEALKENGG ARLAEYHAKA TEHLSTLSEK AKPALEDLRQ
     GLLPVLESFK VSFLSALEEY TKKLNTQ
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024